| Filing date | Description | Form | View |
|---|---|---|---|
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
DEF 14A | View HTML | |
Additional proxy soliciting materials - definitive |
DEFA14A | View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
A statement of beneficial ownership of common stock by certain persons |
SC 13G | View HTML |
Data provided by Kaleidoscope.
2021
2020
Thursday, May 6, 2021 at 9:00 a.m. Pacific Time
The 2021 Annual Meeting of Stockholders of Nurix Therapeutics, Inc. (“Nurix” or the “Company”) was held on Thursday, May 6, 2021.
Stockholders of record of Nurix common stock as of the close of business on March 12, 2021 were entitled to vote at the meeting. A replay of the webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2021 .
'